Regione Liguria – Cinque Terre – Via dell’Amore: On Saturday, July 27, One of the Most Beautiful Trails in the World, a Symbol of Liguria, Will Reopen After 12 Years of Closure
After a long wait, on Saturday, July 27th, the Via dell’Amore will reopen to the public. With just over 900 metres of trail perched over the sea, this iconic symbol of Liguria is one of the most stunning, evocative, and famous pathways in the world. It is located in the natural paradise of Cinque Terre, which was declared a UNESCO World Heritage Site in 1997.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240725501622/en/
View of Via dell'Amore - ph credits Bruno Maderna
Closed since 2012 due to a landslide, the Via dell’Amore was reopened after a complex redevelopment led by the Liguria Region, the Government’s commissioner for management of hydrogeological instability, and in collaboration with Riomaggiore, the Cinque Terre National Park, the Superintendency of Archaeology, Fine Arts, and Landscape, and the Harbour Master’s Office.
The total investment exceeded 23 million euros, with the Liguria Region providing 12 million euros, and additional funding from the Ministry of Culture (6.9 million), the Ministry of Environment (3 million), and Civil Protection (1.5 million).
Reopening the Via dell’Amore was complex due to its fragile cliffside location. Restoration work started on January 14, 2022, and finished on July 19, 2024. Specialist companies worked on-site using helicopters to transport materials while rock workers suspended by ropes and cables performed deep anchorages on the cliff and installed stainless-steel mesh.
On the eve of its reopening, the Via dell’Amore was inaugurated with support from the Ministry of Tourism. The communities of Riomaggiore and Manarola celebrated with key figures including the Minister of Tourism, Daniela Santanchè; the Commissioner for the management of hydrogeological instability, Giacomo Raul Giampedrone; the interim President of the Liguria Region, Alessandro Piana; the President of the Cinque Terre National Park, Donatella Bianchi; and the Mayor of Riomaggiore, Fabrizia Pecunia.
Accompanying the authorities was a train adorned with a design dedicated to the Via dell’Amore, which will remain in service on the route. The day was marked by a captivating fireworks display and a music show.
Going forward, Riomaggiore town will manage the trail as an open-air museum with reserved, limited, and fee-based access to maintain safety measures.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240725501622/en/
Contacts
Emanuela Capitanio
Alessandra Perrucchini +393404212323
press@wondercomunicazione.net
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Daiichi Sankyo Shines a Light on Inequalities and Unmet Needs in Care as Part of Its Commitment to People With Cardiovascular Disease31.8.2024 17:00:00 CEST | Press release
Daiichi Sankyo Europe, (hereafter, Daiichi Sankyo) today announced its reinforced commitment to addressing key unmet needs and barriers in cardiovascular (CV) care, by shining a light on inequalities in treatment and outcomes experienced by various patient groups. The announcement follows the presentation of data from sub-analyses of the SANTORINI observational study and ETNA-AF (Edoxaban Treatment in routiNe clinical prActice in patients with nonvalvular Atrial Fibrillation) study programme, at the European Society of Cardiology (ESC) Congress 2024. Gender inequalities in CV disease treatment and LDL-C goal attainment Raised low-density lipoprotein cholesterol (LDL-C) is a key modifiable contributor to risk of cardiovascular major events. It has been shown that for every 1 mmol/L reduction in LDL-C, there is a 22% reduction in major cardiovascular events after 1 year.7,8 Female patients in Europe who are at high or very high CV risk were undertreated and less achieved guideline-recomm
Suzano completes purchase of 15% stake in Lenzing AG31.8.2024 00:40:00 CEST | Press release
Suzano, the world's largest pulp producer, today announces the completion of its acquisition of a 15% stake in Lenzing AG, the Vienna-listed leading global supplier of sustainable premium cellulosic fibres for the textile and non-wovens industry, from B&C Group. As announced in June this year, the transaction value is EUR 230 million (or EUR 39.70 per share). The agreement was subject to regulatory approval, which was granted without restrictions. The long-term partnership between Suzano and B&C Group establishes that Suzano has the right to hold two seats on Lenzing’s Board and the option to acquire an additional 15% stake from B&C Group until the end of 2028. Following the sale of the 15% stake, B&C Group now holds 37.25% of Lenzing’s share capital. Lenzing is a leading global supplier of premium wood-based cellulosic fibers (lyocell, modal, and viscose) for the production of clothing, home textiles, hygiene products, and non-woven materials. Beto Abreu, CEO of Suzano, said: “Lenzing
Ant International Collaborates with Brazilian Partners to Drive Financial Inclusion with Innovative Credit Tech Solutions30.8.2024 20:46:00 CEST | Press release
Ant International, a digital payment and financial technology leader, today announced its strategic initiative to provide AI-driven credit technology solutions designed to empower local partners and advance financial inclusions in Brazil. As a major milestone, Ant International has formed a strategic partnership with Dock, a leader in payments and banking technology in Latin America. This collaboration aims to enhance the credit management capability and infrastructure efficiency for Dock’s clients, which include financial institutions, retailers, fintech start-ups, etc. The shared vision is to make credit services more inclusive for market segments that are currently insufficiently served, such as micro, small and medium-sized enterprises (MSMEs). In the initial phase of the collaboration, Ant International’s AI-driven credit tech solutions, including an automated and intelligent risk management engine, will be explored for integration into Dock One platform. This initiative aims to s
Wipro Appoints Srikumar Rao as Global Head of Its Engineering Edge Business Line30.8.2024 16:20:00 CEST | Press release
Wipro Limited (NYSE: WIT, BSE: 507685, NSE: WIPRO), a leading technology services and consulting company, today announced the appointment of Srikumar Rao as Global Head of its Engineering Edge Business Line, effective from October 5, 2024. Srikumar succeeds Harmeet Chauhan, who is stepping down to pursue opportunities outside the organization. Srikumar will report to Srini Pallia. Srikumar has been with Wipro for 26 years and has grown with the organization, serving in various leadership roles. He was most recently the Chief Operating Officer (COO) of Wipro Engineering Edge (WEE) and Global Practice Head of Embedded Systems. His work has spanned several markets, selling and delivering specialized Engineering, Research, and Development (ER&D) services to Software & Internet, Semiconductor, Automotive, Manufacturing, and Communications clients. In his new role, Srikumar will continue to scale and strengthen Wipro’s engineering prowess. He will also be responsible for defining the vision
Alnylam Presents Detailed Results from the Positive HELIOS-B Phase 3 Study of Vutrisiran▼ in Patients with ATTR Amyloidosis with Cardiomyopathy at the European Society of Cardiology Congress30.8.2024 12:00:00 CEST | Press release
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced detailed results from the HELIOS-B Phase 3 study of vutrisiran, an investigational RNAi therapeutic in development for the treatment of ATTR amyloidosis with cardiomyopathy (ATTR-CM). The data were presented today in a Hot Line session at the European Society of Cardiology (ESC) Congress 2024, taking place August 30-September 2 in London, United Kingdom. Results from the HELIOS-B study were also simultaneously published in TheNew England Journal of Medicine. As previously reported, the HELIOS-B study met all 10 of its primary and secondary endpoints, across both the overall and monotherapy populations, with statistical significance. Enrolled patients were predominantly New York Heart Association (NYHA) Class I or II with wild-type disease and had been diagnosed by non-invasive methods, with substantial concurrent treatment with available standard of care treatments such as tafamidis and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom